BioSante Pharmaceuticals, Inc.
111 Barclay Boulevard
Lincolnshire
Illinois
60069
United States
Tel: 847-478-0500
Fax: 847-478-9152
Website: http://www.biosantepharma.com/
Email: donenber@biosantepharma.com
288 articles about BioSante Pharmaceuticals, Inc.
-
BioSante Pharmaceuticals, Inc. Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
7/16/2013
-
BioSante Pharmaceuticals, Inc. Receives NASDAQ Delisting Determination Letter
6/21/2013
-
BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce Completion of Merger
6/20/2013
-
Leading Independent Proxy Advisory Firms ISS and Glass, Lewis & Co., LLC Recommend Vote “FOR” BioSante Pharmaceuticals, Inc./ANI Merger
6/10/2013
-
BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results
5/13/2013
-
BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger
5/9/2013
-
BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger
5/9/2013
-
BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders to Vote "FOR" Proposed Merger With ANI Pharmaceuticals, Inc.
3/19/2013
-
Glass, Lewis & Co., LLC Recommends Vote "FOR" BioSante Pharmaceuticals, Inc./ANI Pharmaceuticals, Inc. Merger
3/4/2013
-
ISS Recommends BioSante Pharmaceuticals, Inc. Merger With ANI Pharmaceuticals, Inc.
2/26/2013
-
BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger
1/23/2013
-
BioSante Pharmaceuticals, Inc. Reports Third Quarter Financial Results and Merger Update
11/9/2012
-
BioSante Pharmaceuticals, Inc. to Present at Biotechnology Industry Organization (BIO) Investor Forum
10/8/2012
-
BioSante Pharmaceuticals, Inc. to Merge With ANI Pharmaceuticals, Inc. in All-Stock Deal
10/4/2012
-
BioSante Pharmaceuticals, Inc. Announces Positive LibiGel® Phase III Safety Data Review and Decision to Conclude the Safety Study
9/4/2012
-
BioSante Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare Conference and Rodman & Renshaw Global Investment Conference
8/30/2012
-
BioSante Pharmaceuticals, Inc. Closes $3,475,000 Registered Direct Offering
8/21/2012
-
BioSante Pharmaceuticals, Inc. to Raise $3,475,000 in Registered Direct Offering
8/17/2012
-
BioSante Pharmaceuticals, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
6/19/2012
-
BioSante Pharmaceuticals, Inc. Announces New LibiGel® Phase III Efficacy Trials
6/11/2012